News
Public · Published
Mankind Pharma, AIOS And EBAI Join Hands To Promote Eye Health Awareness
Mankind Pharma, with the All India Ophthalmological Society and the Eye Bank Association of India, organised Vision Continuum 2026 to raise awareness about corneal health, eye donation, childhood myopia and preventive eye care, and introduced a Vision Growth Card to track children's visual development.
Published:
Updated:
What happened
Mankind Pharma, with the All India Ophthalmological Society and the Eye Bank Association of India, organised Vision Continuum 2026 to raise awareness about corneal health, eye donation, childhood myopia and preventive eye care, and introduced a Vision Growth Card to track children's visual development.
Confirmed
Global impact / market context
The Vision Growth Card ties Mankind Pharma's brand to routine children's eye checkups, which could support demand for related eye-care products and services and deepen relationships with eye doctors, though the article gives no revenue, cost or sales figures.
Analyst inference
The article points to a gap between demand for donor corneas and their availability in India, and stresses early detection of childhood myopia, suggesting the eye-care market relies on awareness and regular screening rather than only on treatment.
Analyst inference
What to watch
- The Vision Growth Card was made with the All India Ophthalmological Society to help track children's visual development and encourage regular follow-ups between parents and eye-care professionals. Confirmed
- Watch whether Mankind Pharma expands the Vision Growth Card beyond the launch event into ongoing programmes, which would signal a lasting commitment to preventive eye care rather than one-off awareness. Proposed
- Track whether the corneal donation gap and childhood myopia screening discussed at Vision Continuum 2026 lead to concrete partnerships, since those would show how awareness converts into real eye-care services. Analyst inference
Evidence
- Original source link unavailable